Cempra’s Solithromycin Demonstrates No QT Effects in Thorough QT Study

[at noodls] – CHAPEL HILL, N.C., Feb. 11, 2014 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs … more

View todays social media effects on CEMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Cempra is hiring next, click here to view